Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today …
![Xylyx Bio and Vanderbilt University Agreement](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/05/Xylyx_Bio__By_repairing_donor_organs_deemed_unfit_for_transplant_the_organ_rehabilitation_platform.jpg?resize=600%2C427&ssl=1)
![Xylyx Bio and Vanderbilt University Agreement](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/05/Xylyx_Bio__By_repairing_donor_organs_deemed_unfit_for_transplant_the_organ_rehabilitation_platform.jpg?resize=600%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today …
A novel study has shown that Senolytics, a new class of drugs, have the potential …
In a medical landscape often marred by tales of despair, the successful lung transplant at …